Parkinson’s Disease and Movement Disorders Center, Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA
Copyright © 2023 The Korean Movement Disorder Society
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
• Entering the genetic status of a patient harboring a mutation in the Huntingtin gene
• Creating a letter that details a Parkinson patient’s legal or financial struggles secondary to impulse control disorders
• Preparing a dossier for an ataxia patient that is planning on applying for permanent disability
Ethics Statement
This manuscript is not the product of a study that was submitted to the University of Pennsylvania’s Institutional Review Board. Informed patient consent was not necessary or acquired for this work.
Conflicts of Interest
The author declares that there are no conflicts of interest relevant to this work. However, over the previous 12 months, the author has served as site Principal Investigator for clinical trials and received research support from Insightec, Teva Pharmaceuticals, Cerevel Therapeutics, Prevail Therapeutics, Addex Pharmaceuticals and Lundbeck Therapeutics. The author has also received publishing royalties from a UpToDate and Elsevier.
Funding Statement
None